# FDA EIR - KBI Biopharma, Inc. - January 13, 2022

Source: https://www.globalkeysolutions.net/records/eir/kbi-biopharma-inc/a81226aa-426d-46d9-944c-5f2d9fe32b8b

> FDA EIR for KBI Biopharma, Inc. on January 13, 2022. Product: Biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: KBI Biopharma, Inc.
- Inspection Date: 2022-01-13
- Product Type: Biologics
- Office Name: Office of Pharmaceutical Quality Operations

## Related Documents

- [EIR - 2022-01-13](https://www.globalkeysolutions.net/records/eir/kbi-biopharma-inc/30c356bd-9d01-4bab-921c-1b4df3651548)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/kbi-biopharma-inc/b2e5c387-c4aa-43e0-9e1a-4df5af2fb450)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/kbi-biopharma-inc/95ddec2e-c9f9-4afa-b553-ef1a9544c454)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/kbi-biopharma-inc/1cedc47d-94d6-4c1d-ac32-6a732db2ad68)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/kbi-biopharma-inc/fd287876-5a12-475f-b822-21862842a0b3)

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/donald-kerkow/156eeed4-e6fe-4981-97b8-3f98cfecbfa0)
- [recipient](https://www.globalkeysolutions.net/people/sigma-mostafa/255d161f-b8cf-4447-a9bf-d1c4e1a732a8)
- [company_representative](https://www.globalkeysolutions.net/people/allison-dickens/39a8a683-8b65-4de7-b287-310c080ef783)
- [Seneca D. Toms](https://www.globalkeysolutions.net/people/seneca-d-toms/3eda62a2-4c12-438f-805a-5e3efb0f2f94)
- [company_representative](https://www.globalkeysolutions.net/people/glenn-barbrey/8a7dbfbb-8a8c-44b1-aa8b-87c9114da6a3)

Company: https://www.globalkeysolutions.net/companies/kbi-biopharma-inc/c19eb9d6-d05c-437c-b018-992dba71d288

Office: https://www.globalkeysolutions.net/offices/office-of-pharmaceutical-quality-operations/6b0153a9-c1d1-46a5-8b10-836d2ae44ffe